JI-CJ001 Enhances Paclitaxel Sensitivity in Gastric Cancer Cell Lines through Inhibition of HER2/mTOR Signaling and Induction of Autophagy

Collectively, these findings indicate that JI-CJ001 enhances the therapeutic impact of PTX in gastric cancer cell lines through regulation of HER2/mTOR signaling and autophagy. These results highlight JI-CJ001 as a promising natural adjuvant for improving the efficacy of conventional chemotherapy in gastric cancer.